人福醫藥上半年凈利同比增長17%
上(shang)(shang)證報中國(guo)證券網(wang)訊(記(ji)者 孔子元)人福(fu)醫藥披(pi)露(lu)半(ban)年(nian)(nian)報,2020年(nian)(nian)上(shang)(shang)半(ban)年(nian)(nian)營業收(shou)入96.56億(yi)元,較上(shang)(shang)年(nian)(nian)同(tong)期(qi)減少8.23%;實現歸屬于(yu)上(shang)(shang)市(shi)公司股東的凈利潤3.92億(yi)元,較上(shang)(shang)年(nian)(nian)同(tong)期(qi)增加16.56%,實現歸屬于(yu)上(shang)(shang)市(shi)公司股東的扣(kou)除(chu)非經常(chang)性損(sun)益的凈利潤3.73億(yi)元,較上(shang)(shang)年(nian)(nian)同(tong)期(qi)增長14.20%。每(mei)股收(shou)益0.29元。